abstract |
The invention relates to a pharmaceutical composition comprising fulvic acid, a resveratrol derivative, optionally at least one boron-containing compound or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, in particular for the treatment or prevention of inflammatory skin disorders. |